“INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING” (2026) Frontier in Medical and Health Research, 4(5), pp. 567–585. Available at: https://fmhr.net/index.php/fmhr/article/view/2904 (Accessed: 21 May 2026).